Dopamine (DA) is the most abundant catecholamine in the brain. The involvem
ent and importance of DA as a neurotransmitter in the regulation of differe
nt physiological functions in the central nervous system (CNS) is well know
n. Deregulation of the dopaminergic system has been linked with Parkinson's
disease, Tourette's syndrome, schizophrenia, attention deficit hyperactive
disorder (ADHD) and generation of pituitary tumours. This review focuses o
n the pharmacological and biochemical features shared by the dopamine recep
tors. We address their coupling to secondary messenger pathways and their p
hysiological function based upon studies using pharmacological tools, speci
fic brain lesions and, more recently, genetically modified animal models. (
C) 2000 Elsevier Science Ltd. All rights reserved.